Gamma globulin treatment for critically ill children with inflammation surge
Part of Infections clinical trials.
This trial studies whether giving “human gamma globulin” can improve outcomes in very sick children in the ICU who have a severe infection causing an extreme inflammation reaction (“inflammatory storm”). If you’re in the hospital ICU with this complication, the study may offer a targeted treatment strategy and careful monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a child currently hospitalized in the PICU (pediatric ICU) at Children’s Hospital of Fudan University
- Have a severe infection that is complicated by an inflammatory “storm” reaction
- Be expected to stay in the hospital longer than 48 hours (not being discharged within 48 hours)
- Have a signed informed consent for the study
- Have complete clinical and demographic information available for study records
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a type of immune cell called gamma delta T cells in patients who are very sick in the ICU, including those with and without sepsis. The goal is to understand how these cells work differently in these patients, which could help find better treatments.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
This study tests a blood-filtering treatment that may help remove harmful substances from the blood in people with sepsis. It might improve recovery for patients in the intensive care unit (ICU).
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.